AA
NUVB icon

ALPS Advisors’s Nuvation Bio NUVB Stock Holding History

ALPS Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
351,995
+69,844
+25% +$341K 0.01% 523
2026
Q1 		$1.21M Buy
282,151
+1,251
+0.4% +$6.97K 0.01% 548
2025
Q4 		$2.52M Buy
280,900
+116,851
+71% +$724K 0.01% 357
2025
Q3 		$607K Sell
164,049
-18,986
-10% -$51.7K ﹤0.01% 634
2025
Q2 		$357K Sell
183,035
-62,091
-25% -$129K ﹤0.01% 854
2025
Q1 		$431K Sell
245,126
-27,024
-10% -$61.5K ﹤0.01% 610
2024
Q4 		$724K Buy
+272,150
New +$701K ﹤0.01% 554

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ALPS Advisors's NUVB Position: Q2 2026 in Review

ALPS Advisors increased its Nuvation Bio (NUVB) stake by 25% in Q2 2026, buying an estimated $341K and bringing the position to 351,995 shares worth $2M. The position accounts for 0.01% of the portfolio, ranked #523.

ALPS Advisors first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.52M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • ALPS Advisors held 351,995 shares of Nuvation Bio worth $2M as of Q2 2026.
  • ALPS Advisors bought 69,844 Nuvation Bio shares in Q2 2026, an estimated $341K.
  • Nuvation Bio made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #523 holding.
  • ALPS Advisors first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • ALPS Advisors's Nuvation Bio position peaked at $2.52M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.